Department of Translational Molecular Pathology, Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Trends Cancer. 2023 Nov;9(11):874-875. doi: 10.1016/j.trecan.2023.09.005. Epub 2023 Sep 29.
Benzodiazepines (BZDs) are commonly prescribed for pancreatic cancer patients. To investigate the correlation between BZDs and survival outcomes a recent study by Cornwell et al. found that lorazepam (LOR) correlates with poor survival. The mechanistic study shows that LOR increases interleukin 6 (IL6) expression in cancer-associated fibroblasts via GPR68.
苯二氮䓬类药物(BZDs)常用于胰腺癌患者。为了研究 BZDs 与生存结果的相关性,Cornwell 等人最近的一项研究发现,劳拉西泮(LOR)与生存不良相关。机制研究表明,LOR 通过 GPR68 增加癌症相关成纤维细胞中白细胞介素 6(IL6)的表达。